Lorenzo Leoni ^Investor

Lorenzo Leoni is a serial entrepreneur and active investor with expertise in translational medicine and start-up management. As the Founder and CEO of BioPharmaTi, Elion Oncology, and Gain Therapeutics, he has a proven track record of developing successful biopharmaceutical companies. With a background in biochemistry and cell biology, as well as experience as an Assistant Professor at UCSD, he brings a strong scientific and regulatory understanding to his ventures. Leoni's achievements include the sale of Salmedix Inc for 200M USD and Telormedix after Phase 2 trials. He is known for his excellent fundraising skills and extensive network in the US and EU biotech industries. (100 words)